AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimivos M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Medliva Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimivos M 2mg/500mg Tablet SR

Diabetic patients may find relief with Glimivos M 2mg/500mg SR tablets, a dual-action antidiabetic medication. This formulation combines two active components to manage type 2 diabetes in adults by regulating blood glucose. Always ingest this medication with food, maintaining a consistent daily schedule for optimal efficacy. Dosage is personalized and adjusted by your physician based on your blood sugar response. Continuous use is crucial; abrupt cessation, without medical supervision, can lead to elevated blood sugar, risking complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood sugar monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential under your doctor's guidance.

Primary Ingredients of Glimivos M 2mg/500mg Tablet SR

There is no text provided to rephrase.

Uses of Glimivos M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimivos M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimivos M 2mg/500mg Tablet SR whole; do not chew, grind, or fracture it. Administer this medication with a meal.

Common Side effects of Glimivos M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimivos M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimivos M 2mg/500mg Sustained-Release tablets should be taken with a meal.

How Glimivos M 2mg/500mg Tablet SR works:

Glimivos M SR tablets (2mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimivos M 2mg/500mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimivos M 2mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimivos M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimivos M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimivos M 2mg/500mg SR tablets. Physician consultation is recommended. Regular monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimivos M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimivos M 2mg/500mg Tablet SR :

Should you forget to take your Glimivos M 2mg/500mg SR tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimivos M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimivos M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimivos M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimivos M 2mg/500mg Tablet SR and seek immediate medical attention.
Glimivos M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimivos M 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimivos M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimivos M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimivos M 2mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and increase the risk of lactic acidosis.
Glimivos M 2mg/500mg Tabl...
61
MRP 71
14% off